Product Information
TRIAZOLAM 0.125 MG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.3397 per EA under NDC 50742064501. Its NADAC has been published 274 times since Mar 31, 2021.
Strength
.125 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742064501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TRIAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA214219On Market Since
10/20/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIAZOLAM 0.125 MG TABLET has been published 274 times since Mar 31, 2021, and over the history we have for it it has declined 74.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3397 per EA |
|---|---|
| All-time high | $1.5231 (Apr 13, 2022) |
| All-time low | $0.2219 (Jan 22, 2025) |
| 52-week high | $0.3975 |
| 52-week low | $0.3206 |
| Median price | $0.8000 |
| Average price | $0.7188 |
| Largest weekly change | +49.3% (Mar 23, 2022) |
| Weeks tracked | 274 |
| Tracking since | Mar 31, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRIAZOLAM 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TRIAZOLAM 0.125 MG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $0.3397 per EA (NDC 50742064501), effective Jun 24, 2026.
How has the price of TRIAZOLAM 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for TRIAZOLAM 0.125 MG TABLET has declined 74.6%. It has been tracked across 274 weekly CMS publications since Mar 31, 2021.
What are the highest and lowest recorded NADAC prices for TRIAZOLAM 0.125 MG TABLET?
Since Mar 31, 2021, the NADAC for TRIAZOLAM 0.125 MG TABLET has ranged from a low of $0.2219 (Jan 22, 2025) to a high of $1.5231 (Apr 13, 2022), with a median of $0.8000 per EA.
Are there cheaper alternatives to TRIAZOLAM 0.125 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TRIAZOLAM 0.125 MG TABLET, but none are currently priced below it.
Who manufactures TRIAZOLAM 0.125 MG TABLET?
TRIAZOLAM 0.125 MG TABLET (NDC 50742064501) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification